| dc.contributor.author | Aas, Christer Frode | |
| dc.contributor.author | Vold, Jørn Henrik | |
| dc.contributor.author | Skurtveit, Svetlana | |
| dc.contributor.author | Lim, Aaron G. | |
| dc.contributor.author | Ruths, Sabine | |
| dc.contributor.author | Islam, Kamrul | |
| dc.contributor.author | Askildsen, Jan Erik | |
| dc.contributor.author | Løberg, Else-Marie | |
| dc.contributor.author | Fadnes, Lars T. | |
| dc.contributor.author | Johansson, Kjell Arne | |
| dc.date.accessioned | 2022-10-10T09:06:45Z | |
| dc.date.available | 2022-10-10T09:06:45Z | |
| dc.date.created | 2021-02-18T12:59:01Z | |
| dc.date.issued | 2020 | |
| dc.identifier.issn | 1747-597X | |
| dc.identifier.uri | https://hdl.handle.net/11250/3024985 | |
| dc.description.abstract | Opioid dependence carries the highest disease burden of all illicit drugs. Opioid agonist therapy (OAT) is an evidence-based medical intervention that reduces morbidity and mortality. There is limited knowledge on the health-related quality of life (HRQoL) of long-term patients in OAT. This study measures HRQoL and self-perceived health of long-term patients on OAT, compares the scores to a Norwegian reference population, and assesses changes in these scores at 1-year follow up. | |
| dc.language.iso | eng | |
| dc.relation.uri | https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-020-00309-y | |
| dc.title | Health-related quality of life of long-term patients receiving opioid agonist therapy: A nested prospective cohort study in Norway | |
| dc.type | Peer reviewed | |
| dc.type | Journal article | |
| dc.description.version | publishedVersion | |
| dc.source.volume | 15 | |
| dc.source.journal | Substance Abuse Treatment, Prevention, and Policy | |
| dc.identifier.doi | http://dx.doi.org/10.1186/s13011-020-00309-y | |
| dc.identifier.cristin | 1891343 | |
| cristin.ispublished | true | |
| cristin.fulltext | original | |
| cristin.qualitycode | 1 | |
